Diabetic drug Avandia in trouble

The antidiabetic drug rosiglitazone is in big trouble as the decisions from major regulatory bodies were announced today. The European Medicines Agency (EMA) announced today that it is recommending … [Read more...]

Pharma news, 23 July

Money troubles for European drug makers? Check out the latest buzz in the pharmaceutical industry. Roche May Lose $1 Billion a Year on Avastin Change The anti-cancer drug Avastin … [Read more...]

Another side to mammograms: the German perspective

Whereas the Americans are debating about increasing the starting age of mammography screening from 40 to 50, some countries in Europe are debating about getting rid of routine mammogram screening. Let … [Read more...]

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.